DK662887D0 - Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf - Google Patents

Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf

Info

Publication number
DK662887D0
DK662887D0 DK662887A DK662887A DK662887D0 DK 662887 D0 DK662887 D0 DK 662887D0 DK 662887 A DK662887 A DK 662887A DK 662887 A DK662887 A DK 662887A DK 662887 D0 DK662887 D0 DK 662887D0
Authority
DK
Denmark
Prior art keywords
flatherical
preparing
therapy system
therapy
flatherical therapy
Prior art date
Application number
DK662887A
Other languages
English (en)
Other versions
DK170434B1 (da
DK662887A (da
Inventor
Karin Wolter
Fritz Herrmann
Hans Rainer Hoffmann
Guenter Simon
Thomas Kissel
Joerg Reinhardt
Original Assignee
Lohmann Gmbh & Co Kg
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Gmbh & Co Kg, Sandoz Ag filed Critical Lohmann Gmbh & Co Kg
Publication of DK662887D0 publication Critical patent/DK662887D0/da
Publication of DK662887A publication Critical patent/DK662887A/da
Application granted granted Critical
Publication of DK170434B1 publication Critical patent/DK170434B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D34/00—Containers or accessories specially adapted for handling liquid toiletry or cosmetic substances, e.g. perfumes
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
DK662887A 1986-04-17 1987-12-16 Fladeformigt terapeutisk system, fremgangsmåder til fremstilling deraf og anvendelse deraf DK170434B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3613002 1986-04-17
DE3613002 1986-04-17
DE3634016 1986-10-06
DE19863634016 DE3634016A1 (de) 1986-04-17 1986-10-06 Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
PCT/DE1987/000174 WO1987006144A1 (en) 1986-04-17 1987-04-16 Planar therapeutic system, process for its production and its utilization
DE8700174 1987-04-16

Publications (3)

Publication Number Publication Date
DK662887D0 true DK662887D0 (da) 1987-12-16
DK662887A DK662887A (da) 1987-12-16
DK170434B1 DK170434B1 (da) 1995-09-04

Family

ID=25842978

Family Applications (1)

Application Number Title Priority Date Filing Date
DK662887A DK170434B1 (da) 1986-04-17 1987-12-16 Fladeformigt terapeutisk system, fremgangsmåder til fremstilling deraf og anvendelse deraf

Country Status (21)

Country Link
US (1) US5132115A (da)
EP (1) EP0242827B1 (da)
JP (1) JP2542026B2 (da)
KR (1) KR900007178B1 (da)
AU (1) AU608223B2 (da)
CA (1) CA1301005C (da)
CZ (1) CZ284976B6 (da)
DE (2) DE3634016A1 (da)
DK (1) DK170434B1 (da)
ES (1) ES2055692T3 (da)
FI (1) FI89243C (da)
GR (1) GR3003570T3 (da)
HU (1) HU203842B (da)
IE (1) IE59729B1 (da)
IL (1) IL82192A (da)
NZ (1) NZ220016A (da)
PL (1) PL155408B1 (da)
PT (1) PT84674B (da)
SK (1) SK279947B6 (da)
WO (1) WO1987006144A1 (da)
YU (1) YU47135B (da)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
DK158336C (da) * 1987-09-22 1990-10-01 Coloplast As Forbindsmateriale til behandling af saar samt smaalegemer til brug ved fremstilling deraf
DE3809978A1 (de) * 1988-03-24 1989-10-05 Lohmann Gmbh & Co Kg Reservoir fuer gesteuerte wirkstoffabgabe, dieses enthaltende vorrichtung, sowie verfahren zu deren herstellung und verwendung der vorrichtung
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
DE3939376C1 (da) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4110027C2 (de) 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
DK170792B1 (da) * 1992-08-27 1996-01-22 Coloplast As Hudpladeprodukt til dosering af et eller flere medikamenter
EP0661964B1 (en) * 1992-09-25 1997-04-09 Minnesota Mining And Manufacturing Company Skin treatment with adhesion enhancement properties
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
FR2719770A1 (fr) * 1994-05-11 1995-11-17 Lhd Lab Hygiene Dietetique Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation.
GB2292520B (en) * 1994-08-25 1998-09-02 Univ Sheffield Transdermal dressings for animals
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19606025C2 (de) * 1996-02-19 2000-03-30 Wolfram Sterry Verfahren und Vorrichtung zur in vivo-Bestimmung optischer Strahlung innerhalb und unterhalb der Epidermis
DE19650471A1 (de) * 1996-12-05 1998-06-10 Beiersdorf Ag Wirkstoffhaltige Pflaster
DE19706824C1 (de) * 1997-02-21 1998-03-26 Lohmann Therapie Syst Lts Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5958447A (en) * 1998-03-17 1999-09-28 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
DE19820999A1 (de) * 1998-05-11 1999-11-18 Lohmann Therapie Syst Lts Laminat zum Aufbringen auf einen Akzeptor
DE19830732B4 (de) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
JP2002539127A (ja) 1999-03-08 2002-11-19 メディキュア インコーポレーテッド ビタミンｂ−６障害のためのピリドキサル類縁体
DE19911262C2 (de) * 1999-03-13 2003-04-10 Scs Skin Care Systems Gmbh Vorrichtung zur Abgabe kosmetischer Wirkstoffe
DE19912477A1 (de) * 1999-03-19 2000-09-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System und Verfahren zu seiner Herstellung
US6183770B1 (en) * 1999-04-15 2001-02-06 Acutek International Carrier patch for the delivery of agents to the skin
US6328988B1 (en) * 1999-04-23 2001-12-11 Rutgers, The State University Of New Jersey Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
WO2001003682A2 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003507418A (ja) 1999-08-24 2003-02-25 メディキュア インターナショナル インコーポレイテッド 心血管疾患とその関連疾患の治療
WO2001054661A1 (en) * 2000-01-28 2001-08-02 The Procter & Gamble Company Cleansing articles containing isolated benefit areas
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
EP1299358B1 (en) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
DE10056009A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung hyperämisierender Wirkstoffe
FR2822711B1 (fr) * 2001-03-28 2003-06-13 Oreal Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4865958B2 (ja) 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
EP1414784A2 (en) * 2001-07-12 2004-05-06 Rutgers, The State University Of New Jersey Amphiphilic star-like macromolecules for drug delivery
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
AR047936A1 (es) * 2003-04-30 2006-03-15 Purdue Pharma Ltd Forma de dosificacion transdermica resistente a la manipulacion
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US20070059351A1 (en) * 2003-10-17 2007-03-15 Murrell George A C Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
US20070053966A1 (en) * 2003-10-17 2007-03-08 Robert Ang Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
US20060286159A1 (en) * 2003-10-17 2006-12-21 Calvert Murrell George A Treatment of persistent active tendinopathy using transdermal glyceryl trinitrate providing durability of effect
US20060286158A1 (en) * 2003-10-17 2006-12-21 Calvert Murrell George A Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
US20050181029A1 (en) * 2004-02-18 2005-08-18 Samir Mitragotri Distributed drug dispensing matrix as a transdermal patch
CA2570048A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006023644A2 (en) * 2004-08-20 2006-03-02 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
US8312836B2 (en) * 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036969A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Formation of barrier layer
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
ATE471146T1 (de) 2004-10-21 2010-07-15 Durect Corp Transdermale verabreichungssysteme
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7332268B2 (en) * 2005-04-07 2008-02-19 Bio-Rad Laboratories, Inc. Layered support sheet for high-yield spot cutting from gels or membranes
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
US20070202155A1 (en) * 2006-02-03 2007-08-30 Cure Therapeutics, Inc. Low dose no donor-containing transdermal patch
US20070259026A1 (en) * 2006-04-20 2007-11-08 Robert Ang Vasodialating dressing for use with intravenous catheters
GB0610096D0 (en) * 2006-05-22 2006-06-28 Walker Adam Anti viral spreader
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US20080108351A1 (en) * 2006-11-06 2008-05-08 Ut Starcom, Inc. Seamless transmission of media traffic for roaming mobile terminals during handoffs
NZ589742A (en) * 2008-05-27 2012-06-29 Univ Melbourne Methods of treating mammals with eustachian tube dysfunctions with betahistine
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
DE102009056746A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
CA2832451A1 (en) 2011-04-04 2012-10-11 The Procter & Gamble Company Home care article
MX355294B (es) 2011-08-15 2018-04-12 Procter & Gamble Artículos para el cuidado personal que tienen composiciones para el cuidado personal que tienen múltiples zonas amoldables.
EP2744340A2 (en) 2011-08-15 2014-06-25 The Procter and Gamble Company Personal care methods
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201211309D0 (en) * 2012-06-26 2012-08-08 Fujifilm Mfg Europe Bv Process for preparing membranes
US11547676B2 (en) 2012-12-28 2023-01-10 Teikoku Seiyaku Co., Ltd. Extended buprenorphine transdermal delivery compositions and methods for using the same
MX360413B (es) 2013-06-27 2018-10-30 Procter & Gamble Composiciones conservantes para el cuidado personal.
US9756923B2 (en) * 2013-07-25 2017-09-12 Amg Co., Ltd. Container for cosmetic material
US20170042311A1 (en) 2014-10-21 2017-02-16 The Procter & Gamble Company Method of Improving Skin Appearance
WO2017070080A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US10576023B2 (en) 2015-10-22 2020-03-03 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US10835499B2 (en) * 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration
CN109922796B (zh) 2016-06-23 2023-04-07 考里安有限责任公司 具有亲水和疏水域的粘合剂基质和治疗剂
US9993466B2 (en) 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
CN110049803B (zh) 2017-01-09 2022-06-07 宝洁公司 具有可溶性膜的阻隔贴片和改善皮肤外观的方法
EP3641952B1 (en) 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
EP3768249B1 (en) 2018-03-19 2024-04-17 The Procter & Gamble Company Method of making a barrier patch with soluble film
DE102021102555A1 (de) 2021-02-04 2022-08-04 Lts Lohmann Therapie-Systeme Ag. Verfahren zur Herstellung eines Formelements für die Herstellung von Mikroarrays sowie Formelement

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT201781B (de) * 1955-05-26 1959-01-26 Smith & Nephew Verfahren und Vorrichtung zum Aufbringen eines druckempfindlichen, mit einem Lösungsmittel verdünnten Gummiklebstoffs auf poröses Pflastermaterial
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
JPS5348215A (en) * 1976-10-13 1978-05-01 Hitachi Ltd Lubricating device for enclosed electric compressor
FR2435950A1 (fr) * 1978-06-05 1980-04-11 Riker Laboratories Inc Pansement medical comprenant une composition a base de nitroglycerine, sa fabrication et son application
JPS55160716A (en) * 1979-06-01 1980-12-13 Toyo Ink Mfg Co Ltd Preparation of application
JPS609221Y2 (ja) * 1980-05-12 1985-04-02 日東電工株式会社 貼付剤
JPS5721316A (en) * 1980-07-14 1982-02-04 Nitto Electric Ind Co Ltd Plaster
JPS57106616A (en) * 1980-12-22 1982-07-02 Yoshiko Takeno Formentation band
JPS5838212A (ja) * 1981-09-01 1983-03-05 Daikyo Yakuhin Kogyo Kk 貼付剤およびその製造方法
GB8334484D0 (en) * 1983-12-24 1984-02-01 Smith & Nephew Ass Surgical dressing
FR2562800A1 (fr) * 1984-04-11 1985-10-18 Fournier Laboratoires Dispositif pour l'administration percutanee de medicaments
DE3564073D1 (en) * 1984-06-23 1988-09-08 Beiersdorf Ag Self-adhesive plaster
DE3423328A1 (de) * 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg Selbstklebendes pflaster
DE3423293C2 (de) * 1984-06-23 1995-08-24 Lohmann Therapie Syst Lts Selbstklebendes Pflaster
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE8623009U1 (da) * 1986-08-28 1987-03-12 Lohmann Gmbh & Co Kg, 5450 Neuwied, De

Also Published As

Publication number Publication date
DK170434B1 (da) 1995-09-04
ES2055692T3 (es) 1994-09-01
FI89243B (fi) 1993-05-31
YU67987A (en) 1989-10-31
AU7283287A (en) 1987-11-09
HUT46548A (en) 1988-11-28
PT84674A (en) 1987-05-01
IL82192A (en) 1992-09-06
JPH01500115A (ja) 1989-01-19
JP2542026B2 (ja) 1996-10-09
IL82192A0 (en) 1987-10-30
DE3634016A1 (de) 1987-10-29
PL265181A1 (en) 1988-07-21
US5132115A (en) 1992-07-21
WO1987006144A1 (en) 1987-10-22
DE3634016C2 (da) 1992-04-09
KR900007178B1 (ko) 1990-09-29
SK268587A3 (en) 1999-06-11
YU47135B (sh) 1995-01-31
DE3775449D1 (de) 1992-02-06
CZ284976B6 (cs) 1999-04-14
EP0242827A1 (de) 1987-10-28
NZ220016A (en) 1990-03-27
SK279947B6 (sk) 1999-06-11
AU608223B2 (en) 1991-03-28
KR880701119A (ko) 1988-07-25
IE59729B1 (en) 1994-03-23
PL155408B1 (en) 1991-11-29
DK662887A (da) 1987-12-16
GR3003570T3 (da) 1993-03-16
EP0242827B1 (de) 1991-12-27
HU203842B (en) 1991-10-28
FI871399A0 (fi) 1987-03-31
IE870963L (en) 1987-10-17
FI871399A (fi) 1987-10-18
FI89243C (fi) 1993-09-10
CA1301005C (en) 1992-05-19
PT84674B (pt) 1989-11-30
CZ268587A3 (cs) 1998-12-16

Similar Documents

Publication Publication Date Title
DK662887D0 (da) Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf
DK664887A (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK49687D0 (da) (-)-benzhydrylsulfinylacetamid, fremgangsmaade til fremstilling heraf og laegemiddel indeholdende denne forbindelse
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
NO872889D0 (no) Preparat og fremgangsmaate for stimulering av underjordiske formasjoner.
DK618387A (da) Fremgangsmaade til sterilisering
DK522487D0 (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
NO872660D0 (no) Preparat og fremgangsmaate for stimulering av underjordiske formasjoner.
DK521887D0 (da) Substituerede pyrazoliner og fremgangsmaade til fremstilling deraf
DK491087D0 (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK554485A (da) Geltandplejemiddel og fremgangsmaade til fremstilling deraf
DK355387D0 (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK315387A (da) Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK500288A (da) Spaerrevaev og fremgangsmaade til fremstilling heraf
DK362987A (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK251087A (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK485988D0 (da) Bovint placentrat lactogen og fremgangsmaade til fremstilling deraf
DK160087A (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
DK50686A (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf
DK287787A (da) Isoxazolidinonderivater og fremgangsmaade til fremstilling deraf
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired